ACM
GMAB icon

Aquatic Capital Management’s Genmab GMAB Stock Holding History

Aquatic Capital Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,781
Closed -$732K – 1552
2025
Q4 		$732K Buy
23,781
+13,926
+141% +$434K 0.02% 627
2025
Q3 		$302K Buy
+9,855
New +$240K 0.01% 999
2025
Q1 		– Sell
-5,459
Closed -$114K – 1389
2024
Q4 		$114K Buy
+5,459
New +$120K ﹤0.01% 1045
2024
Q3 		– Sell
-27,600
Closed -$694K – 1294
2024
Q2 		$694K Buy
+27,600
New +$783K 0.03% 471
2024
Q1 		– Sell
-23,700
Closed -$755K – 1377
2023
Q4 		$755K Buy
23,700
+11,800
+99% +$370K 0.02% 535
2023
Q3 		$420K Buy
11,900
+3,100
+35% +$118K 0.02% 522
2023
Q2 		$334K Buy
+8,800
New +$351K 0.02% 537
2022
Q2 		– Sell
-100
Closed -$4K – 1337
2022
Q1 		$4K Hold
100
– – 0.01% 866
2021
Q4 		$4K Buy
+100
New +$4.17K 0.01% 969

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Aquatic Capital Management's GMAB Position: Q1 2026 in Review

Aquatic Capital Management sold out of Genmab (GMAB) in Q1 2026, closing a stake of 23,781 shares — an estimated $732K sold.

Aquatic Capital Management first reported a position in GMAB in Q4 2021 and held it in 9 quarters. The position peaked at $755K in Q4 2023. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • Aquatic Capital Management reported no remaining Genmab position as of Q1 2026 after selling out during the quarter.
  • Aquatic Capital Management sold 23,781 Genmab shares in Q1 2026, an estimated $732K.
  • Aquatic Capital Management first reported a position in Genmab in Q4 2021 and held it in 9 quarters.
  • Aquatic Capital Management's Genmab position peaked at $755K in Q4 2023.
  • 272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Aquatic Capital Management's 13F filing for Q1 2026, filed 15 May 2026.